TurtleTree, a Singapore- and San Francisco-based maker of cell-based breast milk, has raised $30 million in the first tranche of its Series A funding led by European private equity firm VERSO Capital.
Start your deal-making journey now!
Subscribe now to enjoy unlimited access at just $59.
Premium coverage on private equity, venture capital, and startups in Asia.
Exclusive scoops from our reporters in nine key markets.
In-depth interviews with industry leaders shaping the ecosystem.
Already a Subscriber? Log in
Contact us for corporate subscriptions at subs@dealstreetasia.com
